Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2901e694724c2a759f619944cb7d2a4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-179 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
filingDate |
2005-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2009-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bdebbd9e2c1644d46ce134495a0f095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a8d75c4e66e01f3663f7b304512dc09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c45e6b8bb7dd54f6fa3ba1961891d01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48f77c94b2beeeb5d999a5bf153492f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ab20677a846458d0bab335f4568a8e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_921871fe48886fee965baf33db9b600e |
publicationDate |
2009-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
DK-1824504-T3 |
titleOfInvention |
Anti-tumor combinations containing VEGF trap and 5-fluorouracil or a derivative thereof |
abstract |
This invention relates to antitumor combinations comprising a VEGF inhibitor combined with 5-fluorouracil or with a 5-fluoropyrimidine derivative that are therapeutically useful in the treatment of neoplastic diseases, and pharmaceutical compositions comprising such combinations. |
priorityDate |
2004-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |